Oral Answers to Questions

Vicky Ford Excerpts

Wednesday 6th December 2017 Commons Chamber

[The Prime Minister]

I intend to speak to President Trump about this matter, but our position has not changed—as the right hon. Gentleman says, it has been a long-standing one. It is also a very clear one: the status of Jerusalem should be determined in a negotiated settlement between the Israelis and the Palestinians, and Jerusalem should ultimately form a shared capital between the Israeli and Palestinian states. We continue to support a two-state solution. We recognise the importance of Jerusalem and our position on that has not changed.

[Vicky Ford (Chelmsford) (Con)]

Today, GlaxoSmithKline joined Merck, AstraZeneca and many other companies and charities investing in British bioscience genetics. Does my right hon. Friend agree that this investment in science and research underpins not only jobs but a revolution in medical treatment, which will save lives and give hope to many patients for new treatments?

[The Prime Minister]

I absolutely agree with my hon. Friend. She has highlighted a very important sector for the United Kingdom, and I welcome the investment to which she has referred. That is why this sector is one of the sectors that have been given such significance in the industrial strategy that my right hon. Friend the Business Secretary has published. It is exactly an area where we see benefits in the form not only of investment and jobs in the UK, but, as she says, of improving the treatments available for patients and of improving their lives.